Texture analysis in contrast enhanced CT: New method to predict prognosis of small cell lung cancer treated with platinum-based chemotherapy

被引：0
|
作者：
Wang, M. [1 ]
Ma, X. [1 ]
机构：
[1] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26P
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
    Yi, Yonglin
    Qiu, Zhengang
    Yao, Zifu
    Lin, Anqi
    Qin, Yimin
    Sha, Ruizhan
    Wei, Ting
    Wang, Yanru
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    Shen, Weitao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [2] XPG polymorphisms are associated with prognosis of advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy
    Zou, H. Z.
    Zhao, Y. Q.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 500 - 506
  • [3] Analysis of prognosis in non-small cell lung cancer patients with platinum-based chemotherapy and bone marrow suppression
    Han, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Contrast-Enhanced CT Texture Analysis: a New Set of Predictive Factors for Small Cell Lung Cancer
    Chen, Chaoyue
    Ou, Xuejin
    Li, Hui
    Zhao, Yanjie
    Zhao, Fengnian
    Zhou, Shengliang
    Ma, Xuelei
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (03) : 745 - 751
  • [5] Contrast-Enhanced CT Texture Analysis: a New Set of Predictive Factors for Small Cell Lung Cancer
    Chaoyue Chen
    Xuejin Ou
    Hui Li
    Yanjie Zhao
    Fengnian Zhao
    Shengliang Zhou
    Xuelei Ma
    Molecular Imaging and Biology, 2020, 22 : 745 - 751
  • [6] Lymphocyte subsets predict clinical outcomes of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    Liu, Y.
    Wang, J.
    Liu, L.
    Xu, X.
    Mi, X.
    Shao, M.
    Chen, D.
    Li, S.
    Xiao, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S890 - S890
  • [7] Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
    Perez-Ramirez, Cristina
    Canadas-Garre, Marisa
    Angel Molina, Miguel
    Robles, Ana I.
    Jose Faus-Dader, Maria
    Angel Calleja-Hernandez, Miguel
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2017, 771 : 32 - 58
  • [8] Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy
    Ishii, Hidenobu
    Azuma, Koichi
    Kawahara, Akihiko
    Matsuo, Norikazu
    Tokito, Takaaki
    Hoshino, Tomoaki
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 269 - 271
  • [9] Association of polymorphisms in translesion synthesis genes with prognosis of advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
    Zhang, Xuelin
    Chen, Qun
    Chen, Jia
    He, Chunya
    Mao, Jianlin
    Dai, Yuechu
    Yang, Xi
    Hu, Wei
    Zhu, Chengchu
    Chen, Baofu
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 113 (01) : 17 - 23
  • [10] Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy
    Hidenobu Ishii
    Koichi Azuma
    Akihiko Kawahara
    Norikazu Matsuo
    Takaaki Tokito
    Tomoaki Hoshino
    Investigational New Drugs, 2021, 39 : 269 - 271
12345